Pilot initiative for rare diseases to lay the foundation for the adoption of precision health across Canada
Genomics-based precision health is transformational, promising to improve patient health and increase efficiency of health-care delivery. Today, Genome Canada launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step.
A research team from Memorial University of Newfoundland has been recognized with a 2018 Governor General Innovation Award. Drs. Terry-Lynn Young, Sean Connors, Kathleen Hodgkinson and Daryl Pullman are receiving the award for identifying a lethal gene mutation known to have caused sudden cardiac death in more than 25 Newfoundland and Labrador families.
Synthetic biology creatively combines biology and engineering to produce innovations across multiple sectors. It is a multidisciplinary field of science and technology – based on a strong genomics foundation – that promises to unlock new solutions to some of the world’s most vexing problems, from food security to climate change to cancer treatment.
On April 24, 2018, the Royal Netherlands Academy of Arts and Sciences announced that they have awarded the 2018 Dr. A.H. Heineken Prize for Environmental Sciences to University of Guelph biologist Paul D.N. Hebert. The Research Chair in Molecular Biodiversity at the University of Guelph, Dr. Hebert is receiving the Heineken Prize for his “pivotal contribution to developing a genetic barcode capable of classifying every biological species on Earth.”
Genome Canada is pleased to advise the research community of an upcoming funding opportunity – the 2018 Large-Scale Applied Research Project Competition: Genomics Solutions for Agriculture, Agri-food, Fisheries and Aquaculture. This Competition is anticipated to be formally launched in June 2018 with detailed guidelines and application forms available at that time. Genome Canada is in discussion with other organizations as potential partners for this competition.